CONCORD BIOTECH LIMITED Quarterly Results (CONCORDBIO) — Q2 FY27

Revenue trend and demand read-through

Topline for Q2 FY27 came in at ₹309 cr against ₹247 cr in Q2 FY26, and ₹257 cr in the preceding Q1 FY27 quarter.

On a sequential basis revenue grew +20.0%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.

Total expenses for the quarter were ₹223 cr, or 72.2% of revenue, with operating profit grew +22.7% year on year.

Margins, tax and profitability

Net profit of ₹70.65 cr works out to a net margin of 22.9% compared with 25.7% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.

Below the operating line, CONCORD BIOTECH LIMITED reported profit before tax of ₹95.48 cr, a tax charge of ₹25.91 cr (effective rate 27.1%), interest cost of ₹0.03 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.

Sequentially, net profit moved from ₹57.7 cr in Q1 FY27 to ₹70.65 cr in Q2 FY27, a change of +22.5%.

Trailing twelve months and annual context

Across the trailing four quarters CONCORD BIOTECH LIMITED has generated revenue of ₹1,170 cr and net profit of ₹281 cr, a trailing net margin of 24.0%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.

On a full-year basis, FY26 revenue was ₹1,046 cr with net profit of ₹261 cr and EPS of ₹24.78, versus the prior year where revenue declined -11.3% and profit declined -29.8%.

What to watch in the next CONCORDBIO quarter

For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.

No next results date is available in the board-meeting calendar. Statement figures update when Yahoo Finance makes them available; this is not an immediate exchange-filing feed.

Financial figures here are supplied through Yahoo Finance fundamentals and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.